Figure 1 | Targeting epigenetics for cancer therapy | SpringerLink
Frontiers | Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy | Oncology
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer | Anticancer Research
Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology
Histone Acetyltransferases (HATs) Involved in Non-Homologous End Joining as a Target for Radiosensitization | IntechOpen
Effects of HDAC inhibitors in cancer cells. In healthy cells, promoters... | Download Scientific Diagram
Gururaj M. Shivashimpi's Blog: Histone Deacetylase Inhibition and Cancer Therapy
Histone acetyltransferases: challenges in targeting bi-substrate enzymes | Clinical Epigenetics | Full Text
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo | Oncogenesis
Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells | Clinical Epigenetics | Full Text
CPTH2 is a Potent Histone Acetyltransferase (HAT) Inhibitor - Network of Cancer Research
HAT inhibitors in cancer therapy - ScienceDirect
Rational Combinations Using HDAC Inhibitors | Clinical Cancer Research
Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases - ScienceDirect
Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition | Drug Metabolism & Disposition
Frontiers | Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus | Cell and Developmental Biology
KATs in cancer: functions and therapies | Oncogene
Frontiers | Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy | Oncology
Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
Histone acetyltransferase (HAT) activation as a therapeutic strategy.... | Download Scientific Diagram
HAT inhibitors and activators, their target histone acetyltransferases,... | Download Table
Histone deacetylase modulators provided by Mother Nature | Genes & Nutrition | Full Text
The role of histone deacetylases (HDACs) in human cancer - Ropero - 2007 - Molecular Oncology - Wiley Online Library
Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment
Cureus | Advances in Epigenetic Cancer Therapeutics
Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT
Emerging Role of Histone Acetyltransferase in Stem Cells and Cancer
